Literature DB >> 32637923

High-Energy Flux Density Extracorporeal Shock Wave Therapy Versus Traditional Physical Therapy Modalities in Myofascial Pain Syndrome: A Randomized-controlled, Single-Blind Trial.

Ömer Gezgİnaslan1, Sevgi GÜmÜŞ Atalay1.   

Abstract

OBJECTIVES: This study aims to investigate the effects of extracorporeal shock wave therapy (ESWT) on pain, sleep, fatigue, disability, depression, and quality of life (QoL) in patients with myofascial pain syndrome (MPS). PATIENTS AND METHODS: Between March 2018 and September 2018, a total of 94 patients (16 males, 78 females; mean age 44.2±11.94 years; range, 19 to 74 years) with the diagnosis of MPS were included in the study. The patients were divided into two groups. The treatment group consisted of 49 patients and a total of seven sessions of high-energy flux density ESWT (H-ESWT) (0.26 mJ/mm2) were given with three days interval. The control group consisted of 45 patients and the treatment of hot pack, transcutaneous electrical nerve stimulation, and ultrasound was given for five days for two weeks. At baseline and one month after treatment, the visual analog scale (VAS), Short Form-36 (SF-36), Pittsburgh Sleep Quality Index (PSQI), Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale, Neck Disability Index (NDI), and Beck Depression Inventory (BDI) scores were compared between the groups.
RESULTS: There were no statistically significant differences in the age, sex, demographic characteristics, and baseline VAS, SF-36, NDI, BDI, FACIT, and PSQI scores between the groups (p>0.05). In the ESWT group, there was a statistically significant decrease in the VAS, SF-36, NDI, BDI, FACIT, and PSQI scores after treatment compared to the baseline scores, while only the SF-36 subscale scores were statistically significantly higher (p<0.05). There was a statistically significant correlation between the VAS and SF-36 scores and the BDI, NDI, FACIT and PSQI scores after the treatment.
CONCLUSION: Our study results suggest that H-ESWT is more effective than traditional physical therapy methods on pain, QoL, sleep, fatigue, depression, and disability in patients with MPS.
Copyright © 2020, Turkish League Against Rheumatism.

Entities:  

Keywords:  Disability; extracorporeal shock wave therapy; myofascial pain syndrome; quality of life; sleep

Year:  2019        PMID: 32637923      PMCID: PMC7322313          DOI: 10.5606/ArchRheumatol.2020.7496

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  44 in total

1.  Ultrasound therapy for musculoskeletal disorders: a systematic review.

Authors:  Daniëlle A W M van der Windt; Geert J M G van der Heijden; Suzanne G M van den Berg; Gerben Ter Riet; Andrea F de Winter; Lex M Bouter
Journal:  Pain       Date:  1999-06       Impact factor: 6.961

2.  Clinical precision of myofascial trigger point location in the trapezius muscle.

Authors:  V M Sciotti; V L Mittak; L DiMarco; L M Ford; J Plezbert; E Santipadri; J Wigglesworth; K Ball
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

3.  Comparison of high-power pain threshold ultrasound therapy with local injection in the treatment of active myofascial trigger points of the upper trapezius muscle.

Authors:  Halil Unalan; Javid Majlesi; Filiz Yildiz Aydin; Deniz Palamar
Journal:  Arch Phys Med Rehabil       Date:  2011-04       Impact factor: 3.966

4.  Comparison the efficacy of phonophoresis and ultrasound therapy in myofascial pain syndrome.

Authors:  Saime Ay; Sebnem Koldaş Doğan; Deniz Evcik; Ozgün Cakmak Başer
Journal:  Rheumatol Int       Date:  2010-03-31       Impact factor: 2.631

5.  Prospective randomized trial of accelerated re-epithelization of skin graft donor sites using extracorporeal shock wave therapy.

Authors:  Christian Ottomann; Bernd Hartmann; Josh Tyler; Heike Maier; Richard Thiele; Wolfgang Schaden; Alexander Stojadinovic
Journal:  J Am Coll Surg       Date:  2010-07-14       Impact factor: 6.113

6.  Sex- and age-specific incidence of non-traumatic fractures in selected industrialized countries.

Authors:  S W Wade; C Strader; L A Fitzpatrick; Mary S Anthony
Journal:  Arch Osteoporos       Date:  2012       Impact factor: 2.617

7.  The cultural adaptation, reliability and validity of neck disability index in patients with neck pain: a Turkish version study.

Authors:  Emine Aslan; Ayse Karaduman; Yavuz Yakut; Bahar Aras; Ibrahim Engin Simsek; Naciye Yaglý
Journal:  Spine (Phila Pa 1976)       Date:  2008-05-15       Impact factor: 3.468

8.  [Extracorporal shock wave treatment of the achilles tendinitis: Experimental and preliminary clinical results].

Authors:  L Perlick; R Schiffmann; C N Kraft; T Wallny; O Diedrich
Journal:  Z Orthop Ihre Grenzgeb       Date:  2002 May-Jun

9.  Effectiveness of Ultrasound Therapy on Myofascial Pain Syndrome of the Upper Trapezius: Randomized, Single-Blind, Placebo-Controlled Study.

Authors:  Mustafa Aziz Yildirim; Kadriye Öneş; Gökşen Gökşenoğlu
Journal:  Arch Rheumatol       Date:  2018-03-23       Impact factor: 1.472

10.  The effect of extracorporeal shock wave therapy on myofascial pain syndrome.

Authors:  Jong Hyun Jeon; Yun Jae Jung; Ju Youn Lee; Ji Soo Choi; Jeong Hyeon Mun; Won Yong Park; Cheong Hoon Seo; Ki Un Jang
Journal:  Ann Rehabil Med       Date:  2012-10-31
View more
  3 in total

1.  Effects of Repeated Injection of 1% Lidocaine vs. Radial Extracorporeal Shock Wave Therapy for Treating Myofascial Trigger Points: A Randomized Controlled Trial.

Authors:  Areerat Suputtitada; Carl P C Chen; Narin Ngamrungsiri; Christoph Schmitz
Journal:  Medicina (Kaunas)       Date:  2022-03-26       Impact factor: 2.948

2.  Efficacy of extracorporeal shock waves in the treatment of myofascial pain syndrome: a systematic review and meta-analysis of controlled clinical studies.

Authors:  Tao Wu; Sha Li; Jing Ren; Dun Wang; Yanran Ai
Journal:  Ann Transl Med       Date:  2022-02

Review 3.  Efficacy and Effectiveness of Extracorporeal Shockwave Therapy in Patients with Myofascial Pain or Fibromyalgia: A Scoping Review.

Authors:  Marco Paoletta; Antimo Moretti; Sara Liguori; Giuseppe Toro; Francesca Gimigliano; Giovanni Iolascon
Journal:  Medicina (Kaunas)       Date:  2022-07-28       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.